SCHEMBL14288350

SCHEMBL14288350

CC(C)c1ccc(-c2cc(C(F)(F)F)n(C)n2)s1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.55
▸ GAA P10253 3/20 0.49
▸ L3MBTL1 Q9Y468 2/20 0.49
▸ PTGES2 Q9H7Z7 1/20 0.45
▸ POLB P06746 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.35
▸ RXFP1 Q9HBX9 1/20 0.35
▸ PKM P14618 1/20 0.34
▸ FUBP1 Q96AE4 2/20 0.34
▸ RAB9A P51151 4/20 0.33
▸ NPC1 O15118 3/20 0.33
▸ HDAC3 O15379 1/20 0.33
▸ HDAC4 P56524 1/20 0.33
▸ HDAC1 Q13547 1/20 0.33
▸ HDAC7 Q8WUI4 1/20 0.33
▸ HDAC2 Q92769 1/20 0.33
▸ HDAC10 Q969S8 1/20 0.33
▸ HDAC11 Q96DB2 1/20 0.33
▸ HDAC8 Q9BY41 1/20 0.33
▸ HDAC6 Q9UBN7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22536652 0.86 ALDH1A1 (0.51) ALDH1A1GAAL3MBTL1PTGES2POLB
SCHEMBL19229599 0.84 ALDH1A1 (0.40) ALDH1A1GAAL3MBTL1PTGES2POLB
SCHEMBL22350095 0.84 ALDH1A1 (0.49) ALDH1A1GAAL3MBTL1PTGES2POLB
SCHEMBL13471700 0.81 ALDH1A1 (0.60) ALDH1A1GAAL3MBTL1PTGES2POLB
SCHEMBL13719338 0.79 ALDH1A1 (0.52) ALDH1A1GAAL3MBTL1PTGES2POLB
SCHEMBL5674583 0.79 ALDH1A1 (0.58) ALDH1A1GAAL3MBTL1PTGES2POLB
SCHEMBL12568259 0.78 ALDH1A1 (0.56) ALDH1A1GAAL3MBTL1PTGES2POLB
SCHEMBL1596404 0.78 ALDH1A1 (0.48) ALDH1A1GAAL3MBTL1PTGES2POLB
SCHEMBL2569391 0.77 ALDH1A1 (0.59) ALDH1A1GAAL3MBTL1PTGES2POLB
SCHEMBL12620551 0.77 ALDH1A1 (0.55) ALDH1A1GAAL3MBTL1PTGES2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240068009-A1 SUBSTITUTED IMIDAZO[1,2-a]PYRAZINES AS LUCIFERASE SUBSTRATES PROMEGA CORPORATION 2024-02-29 — — US disclosed
US-20240068009-A1 SUBSTITUTED IMIDAZO[1,2-a]PYRAZINES AS LUCIFERASE SUBSTRATES PROMEGA CORPORATION 2024-02-29 — — US disclosed
US-11781168-B2 Process for preparing substituted imidazo[1,2-α]pyrazines PROMEGA CORPORATION (US) 2023-10-10 — — US disclosed
US-11781168-B2 Process for preparing substituted imidazo[1,2-α]pyrazines PROMEGA CORPORATION (US) 2023-10-10 — — US disclosed
US-20210254128-A1 COELENTERAZINE ANALOGUES PROMEGA CORPORATION 2021-08-19 — — US disclosed
US-10800730-B2 Complex and structurally diverse compounds THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2020-10-13 — — US disclosed
US-10669568-B2 Substituted imidazo[1,2-a]pyrazines as luciferase substrates PROMEGA CORPORATION (US) 2020-06-02 — — US disclosed
US-20190241932-A1 COELENTERAZINE ANALOGUES PROMEGA CORPORATION 2019-08-08 — — US disclosed
US-10308975-B2 Substituted imidazo[1,2-a]pyrazines as luciferase substrates PROMEGA CORPORATION (US) 2019-06-04 — — US disclosed
US-20180223330-A1 COELENTERAZINE ANALOGUES JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT 2018-08-09 — — US disclosed
US-20180223330-A1 COELENTERAZINE ANALOGUES JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT 2018-08-09 — — US disclosed
US-20080015190-A1 Inhibitors of Histone Deacetylase MERCK SHARP & DOHME CORP. 2008-01-17 — — US disclosed
US-20080015190-A1 Inhibitors of Histone Deacetylase MERCK SHARP & DOHME CORP. 2008-01-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11781168-B2 Process for preparing substituted imidazo[1,2-α]pyrazines CYP4Z1, CYP2E1, CYP2F1 ALDH1A1 170/4885GAA 2809/4885L3MBTL1 4861/4885
US-20210254128-A1 COELENTERAZINE ANALOGUES AADAC, GLB1, PGLS ALDH1A1 2295/4885GAA 925/4885L3MBTL1 378/4885
US-20190241932-A1 COELENTERAZINE ANALOGUES GLB1, SI, TCF7L2 ALDH1A1 3541/4885GAA 188/4885L3MBTL1 52/4885
US-20180223330-A1 COELENTERAZINE ANALOGUES GLB1, SI, TCF7L2 ALDH1A1 3541/4885GAA 188/4885L3MBTL1 52/4885
US-20080015190-A1 Inhibitors of Histone Deacetylase HDAC5, HDAC1, HDAC4 ALDH1A1 266/4885GAA 141/4885L3MBTL1 2632/4885
US-10308975-B2 Substituted imidazo[1,2-a]pyrazines as luciferase substrates AADAC, PGLS, GLB1 ALDH1A1 1104/4885GAA 1044/4885L3MBTL1 241/4885
US-20240068009-A1 SUBSTITUTED IMIDAZO[1,2-a]PYRAZINES AS LUCIFERASE SUBSTRATES PGLS, AADAC, GLB1 ALDH1A1 1179/4885GAA 1024/4885L3MBTL1 241/4885
US-10800730-B2 Complex and structurally diverse compounds CYP11A1, LSS, CYP17A1 ALDH1A1 3765/4885GAA 985/4885L3MBTL1 4582/4885
US-10669568-B2 Substituted imidazo[1,2-a]pyrazines as luciferase substrates AADAC, PGLS, GLB1 ALDH1A1 1148/4885GAA 985/4885L3MBTL1 244/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback